Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Applegate

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 9, 2020
Impact of the COVID-19 pandemic on interventional cardiology training in the United StatesSamit Shah, Yulanka Castro-Dominguez, Tanush Gupta, et al.
The Journal of Invasive Cardiology|January 2, 2007
PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patientsRobert J Applegate, Mark A Grabarczyk, David C Sane, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2012
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trialsJames B Hermiller, Krishnankutty Sudhir, Robert J Applegate, et al.
Thrombosis Research|March 26, 2004
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levelsJacqueline Saw, Dean J Kereiakes, Kenneth W Mahaffey, et al.
Journal of the American College of Cardiology|December 15, 2010
Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)Dean J Kereiakes, Donald E Cutlip, Robert J Applegate, et al.
The American Journal of Cardiology|January 21, 2011
Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial)Robert J Applegate, Manejeh Yaqub, James B Hermiller, et al.
Circulation|June 6, 2012
Expansion of a regional ST-segment-elevation myocardial infarction system to an entire stateJames G Jollis, Hussein R Al-Khalidi, Lisa Monk, et al.
Circulation. Cardiovascular Interventions|March 23, 2012
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitionsM Hassan Pervaiz, Poornima Sood, Krishnankutty Sudhir, et al.
The American Journal of Cardiology|March 19, 2013
Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 yearsJohn K Forrest, Alexandra J Lansky, Stephanie M Meller, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 8, 2014
Conversations in cardiology: bridging antiplatelet therapy before surgeryMorton J Kern, Robert J Applegate, Malcolm Bell, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 9, 2020
Impact of the COVID-19 pandemic on interventional cardiology training in the United StatesSamit Shah, Yulanka Castro-Dominguez, Tanush Gupta, et al.
The Journal of Invasive Cardiology|January 2, 2007
PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patientsRobert J Applegate, Mark A Grabarczyk, David C Sane, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 15, 2012
Impact of age on clinical outcomes after everolimus-eluting and paclitaxel-eluting stent implantation: pooled analysis from the SPIRIT III and SPIRIT IV clinical trialsJames B Hermiller, Krishnankutty Sudhir, Robert J Applegate, et al.
Thrombosis Research|March 26, 2004
Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levelsJacqueline Saw, Dean J Kereiakes, Kenneth W Mahaffey, et al.
Journal of the American College of Cardiology|December 15, 2010
Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System)Dean J Kereiakes, Donald E Cutlip, Robert J Applegate, et al.
The American Journal of Cardiology|January 21, 2011
Long-term (three-year) safety and efficacy of everolimus-eluting stents compared to paclitaxel-eluting stents (from the SPIRIT III Trial)Robert J Applegate, Manejeh Yaqub, James B Hermiller, et al.
Circulation|June 6, 2012
Expansion of a regional ST-segment-elevation myocardial infarction system to an entire stateJames G Jollis, Hussein R Al-Khalidi, Lisa Monk, et al.
Circulation. Cardiovascular Interventions|March 23, 2012
Periprocedural myocardial infarction in a randomized trial of everolimus-eluting and Paclitaxel-eluting coronary stents: frequency and impact on mortality according to historic versus universal definitionsM Hassan Pervaiz, Poornima Sood, Krishnankutty Sudhir, et al.
The American Journal of Cardiology|March 19, 2013
Evaluation of XIENCE V everolimus-eluting and Taxus Express2 paclitaxel-eluting coronary stents in patients with jailed side branches from the SPIRIT IV trial at 2 yearsJohn K Forrest, Alexandra J Lansky, Stephanie M Meller, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 8, 2014
Conversations in cardiology: bridging antiplatelet therapy before surgeryMorton J Kern, Robert J Applegate, Malcolm Bell, et al.
Pageof 9